Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G
- 1 October 2007
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 293 (4), F1332-F1341
- https://doi.org/10.1152/ajprenal.00319.2007
Abstract
The interaction of renal basolateral organic anion transporter 3 (Oat3) with commonly used pharmacotherapeutics (e.g., NSAIDs, β-lactams, and methotrexate) has been studied extensively in vitro. However, the in vivo role of Oat3 in drug disposition, in the context of other transporters, glomerular filtration, and metabolism, has not been established. Moreover, recent investigations have identified inactive human OAT3 polymorphisms. Therefore, this investigation was designed to elucidate the in vivo role of Oat3 in the disposition of penicillin G and prototypical substrates using an Oat3 knockout mouse model. Oat3 deletion resulted in a doubling of penicillin's half-life (P < 0.05) and a reduced volume of distribution (P < 0.01), together yielding a plasma clearance that was one-half (P < 0.05, males) to one-third (P < 0.001, females) of that in wild-type mice. Inhibition of Oat3 abolished the differences in penicillin G elimination between genotypes. Hepatic accumulation of penicillin was 2.3 times higher in male knockouts (P < 0.05) and 3.7 times higher in female knockouts (P < 0.001). Female knockouts also exhibited impaired estrone-3-sulfate clearance. Oat3 deletion did not impact p-aminohippurate elimination, providing correlative evidence to studies in Oat1 knockout mice that suggest Oat1 governs tubular uptake of p-aminohippurate. Collectively, these findings are the first to indicate that functional Oat3 is necessary for proper elimination of xenobiotic and endogenous compounds in vivo. Thus Oat3 plays a distinct role in determining the efficacy and toxicity of drugs. Dysfunctional human OAT3 polymorphisms or instances of polypharmacy involving OAT3 substrates may result in altered systemic accumulation of β-lactams and other clinically relevant compounds.Keywords
This publication has 35 references indexed in Scilit:
- The human organic anion transporter 3 (OAT3;SLC22A8): genetic variation and functional genomicsAmerican Journal of Physiology-Renal Physiology, 2006
- Implications of genetic polymorphisms in drug transporters for pharmacotherapyCancer Letters, 2006
- INHIBITION OF OAT3-MEDIATED RENAL UPTAKE AS A MECHANISM FOR DRUG-DRUG INTERACTION BETWEEN FEXOFENADINE AND PROBENECIDDrug Metabolism and Disposition, 2006
- Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)] Rapid CommunicationKidney International, 2005
- Functional Consequences of Single Nucleotide Polymorphisms in the Human Organic Anion Transporter hOAT1 (SLC22A6)Journal of Pharmacology and Experimental Therapeutics, 2005
- Rapid Elimination of Cefaclor from the Cerebrospinal Fluid Is Mediated by a Benzylpenicillin-Sensitive Mechanism Distinct from Organic Anion Transporter 3Journal of Pharmacology and Experimental Therapeutics, 2005
- Relative contribution of OAT and OCT transporters to organic electrolyte transport in rabbit proximal tubuleAmerican Journal of Physiology-Renal Physiology, 2004
- RAT AND MOUSE DIFFERENCES IN GENDER-PREDOMINANT EXPRESSION OF ORGANIC ANION TRANSPORTER (OAT1–3;SLC22A6–8) mRNA LEVELSPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2004
- Characterization of tubular functional capacity in humans using para-aminohippurate and famotidineKidney International, 2001
- Binding of estrogen-3-sulfates to stallion plasma and equine serum albuminThe Journal of Steroid Biochemistry and Molecular Biology, 1992